You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enfuvirtide

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Puerto Rico, United States (Emtricitabine, Enfuvirtide, Ritonavir)

Completed
  • HIV Infections
  • Aurora, Colorado
  • +6 more
Oct 28, 2021

HIV Trial in Baltimore (Enfuvirtide, Efavirenz, lamivudine, and tenofovir)

Completed
  • HIV Infections
  • Enfuvirtide
  • Efavirenz, lamivudine, and tenofovir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
May 6, 2021

HIV Trial in Baltimore (Enfuvirtide)

Completed
  • HIV
  • Enfuvirtide
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center
Nov 22, 2021

HIV Trial in Puerto Rico, United States (Enfuvirtide, Amdoxovir)

Completed
  • HIV Infections
  • Denver, Colorado
  • +8 more
Oct 28, 2021

HIV Trial in Puerto Rico, United States (Enfuvirtide)

Completed
  • HIV Infections
  • Enfuvirtide
  • La Jolla, California
  • +24 more
Oct 28, 2021

Antiretroviral Agents in HIV-infected Pregnant Women.

Recruiting
  • HIV Infections
    • Brussels, Belgium
    • +20 more
    Nov 28, 2022

    HIV-1-infection Trial (Bictegravir, Lenacapavir, BIC/LEN FDC)

    Not yet recruiting
    • HIV-1-infection
    • (no location specified)
    Aug 12, 2022

    HIV-1-infection Trial (Fostemsavir 600 MG [Rukobia])

    Recruiting
    • HIV-1-infection
    • Fostemsavir 600 MG [Rukobia]
    • Orlando, Florida
      Orlando Immunology Center
    Sep 20, 2022

    HIV Trial in United States (Mycophenolate mofetil, Amdoxovir)

    Completed
    • HIV Infections
    • Los Angeles, California
    • +16 more
    Oct 28, 2021

    HIV Trial in Worldwide (PENNVAX-G DNA Vaccine, MVA-CMDR Vaccine, Placebo PENNVAX-G Vaccine)

    Completed
    • HIV Infections
    • PENNVAX-G DNA Vaccine
    • +3 more
    • Rockville, Maryland
    • +3 more
    Oct 28, 2021

    Study of Multidrug-Resistant Patient Outcomes With and Without

    Recruiting
    • HIV Infections
    • Multi-Antiviral Resistance
    • No ibalizumab or Pre-ibalizumab treatment
    • On ibalizumab treatment
    • Los Angeles, California
    • +38 more
    Jan 31, 2023

    HIV Trial in Los Angeles, San Diego, Torrance (Maraviroc)

    Completed
    Has Results
    • HIV Infections
    • Los Angeles, California
    • +2 more
    Aug 6, 2020

    HIV Trial in France (triple therapy, dual therapy)

    Completed
    • HIV
    • triple therapy
    • dual therapy
    • Caen, France
    • +15 more
    Nov 30, 2018

    Infection, Human Immunodeficiency Virus, HIV Trial in Austin (GSK1349572)

    Completed
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Austin, Texas
      GSK Investigational Site
    Jun 20, 2019

    HIV Infection Trial in United States (FUZEON [enfuvirtide])

    Terminated
    • HIV Infection
    • FUZEON [enfuvirtide]
    • Hobson City, Alabama
    • +19 more
    Jun 19, 2017

    HIV Trial (Vicriviroc 30 mg, Vicriviroc 20 mg, Placebo)

    Completed
    Has Results
    • HIV Infections
    • Vicriviroc 30 mg
    • +3 more
    • (no location specified)
    May 12, 2021

    Fuzeon in Combination With Antiretroviral Drugs in HIV-1

    Completed
    • HIV Infections
      • Barcelona, Spain
        (unnamed)
      Nov 1, 2016

      HIV Trial in Sofia (enfuvirtide)

      Completed
      • HIV Infections
      • enfuvirtide
      • Sofia, Bulgaria
        (unnamed)
      Nov 1, 2016

      HIV Trial in Canada, Puerto Rico, United States (Optimized Background ARVs, enfuvirtide [Fuzeon])

      Completed
      • HIV Infections
      • Optimized Background ARVs
      • enfuvirtide [Fuzeon]
      • Hobson City, Alabama
      • +26 more
      Nov 1, 2016

      HIV Trial in Bangkok, Chiang Mai, Nonthaburi (Enfuvirtide)

      Completed
      Has Results
      • HIV Infections
      • Enfuvirtide
      • Bangkok, Thailand
      • +4 more
      May 25, 2016

      HIV Trial in Australia (enfuvirtide [Fuzeon], Antiretroviral therapy)

      Withdrawn
      • HIV Infections
      • enfuvirtide [Fuzeon]
      • Antiretroviral therapy
      • Carlton, Australia
      • +6 more
      Aug 23, 2016

      HIV Trial in Australia, United States (Background ARVs, PI, enfuvirtide [Fuzeon])

      Completed
      Has Results
      • HIV Infections
      • Background ARVs
      • +2 more
      • Phoenix, Arizona
      • +37 more
      Jul 7, 2016

      HIV Trial in France (Enfuvirtide, Optimized background antiretroviral regimen (OB))

      Completed
      • HIV Infections
      • Enfuvirtide
      • Optimized background antiretroviral regimen (OB)
      • Aix En Provence, France
      • +70 more
      Apr 5, 2016

      HIV Trial in Puerto Rico, United States (ARV regimen, enfuvirtide [Fuzeon])

      Completed
      • HIV Infections
      • ARV regimen
      • enfuvirtide [Fuzeon]
      • Phoenix, Arizona
      • +105 more
      Nov 1, 2016

      HIV-2 Infection Trial in Dakar (Stribild (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF) 1 tablet daily X 48 weeks)

      Completed
      Has Results
      • HIV-2 Infection
      • Stribild (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF) 1 tablet daily X 48 weeks
      • Dakar, Senegal
        Clinique des Maladies Infectieuses Ibrahima DIOP Mar/CRCF, Centr
      Jun 30, 2018